The FDA is weighing new restrictions on Xeljanz, following clinical trial data linking the drug to an increased risk of heart problems and cancer, according to a new report.…
A new FDA warning indicates Xeljanz side effects may increase the risk of heart problems, including heart attacks, and cancer in patients over 50.…
Actemra is being tested in an ongoing clinical trial as a potential treatment for systemic sclerosis, despite growing concerns linking the drug to heart attacks, strokes, and deaths.…
A new study’s findings indicate that while testosterone gels do not thicken artery walls, they also do not appear to significantly improve quality of life for older men.…
AbbVie is pushing to have a number of cases dismissed for not having submitted complete Plaintiff Fact Sheets, but plaintiffs’ attorneys say the company is trying to game the system to get a tactical advantage in future trials.…
A request for the creation of a Testofen testosterone booster MDL has been rejected due to a lack of cases and other factors.…
Advocates of popular cholesterol drugs have overstated their benefits and downplayed their health risks, according to the findings of a new study.…
A motion has been filed in AndroGel litigation seeking to force the manufacturer to turn over important discovery documents amid claims of delays and unworkable requirements.…
New clinics are opening nationwide selling testosterone drugs as lifestyle enhancement products for men, despite numerous warnings from health care experts and the FDA.…
Plaintiffs are calling for the creation of a Testofen testosterone booster MDL to consolidate all complaints regarding alleged misleading statements about the testosterone booster dietary supplement.…
